Delivering better treatments
Camurus is committed to improving the lives of patients
with severe and chronic diseases
updates
Latest news
Disease areas
Focus on severe and chronic diseases
Developing treatments for diseases within the central nervous system, rare diseases, endocrinology, oncology and supportive care
Events
Upcoming events
-
30 Apr
Annual Report 2024
The Annual Report 2024 is published on 30 April 2025.
-
08 May
Nordea Healthcare Seminar
Camurus’ President & CEO Fredrik Tiberg is presenting at this conference in Stockholm, 8 May. The presentation can be seen by the conference participants. More information will follow closer to the event.
-
15 May
Interim Report January-March 2025
The interim report January-March is published on 15 May 2025.
Latest financial report
Camurus’ Full Year Report 2024
13 February 2025
Annual General Meeting
Camurus’ Annual General Meeting 2025 will be held on Tuesday, 27 May, 2025, at 17.00 CEST at The Loop, Rydbergs torg 4, in Lund, Sweden. Registration for the AGM begins at 16.30 CEST. Registration and/or digital postal voting is done via Euroclear:
https://anmalan.vpc.se/EuroclearProxy/
See Notice of annual general meeting 2025
See documents for annual general meeting 2025
See more information on Camurus’ general meetings
Pipeline
Diversified pipeline with large potential
Camurus’ innovative product candidates are designed to address important unmet medical needs, with the potential to make significant difference in the daily life of patients by improving treatment outcomes, quality of life, and long-term recovery.
sustainability
Sustainable solutions for a healthier world
Ensuring the long-term successful development of our business – for the benefit of patients, healthcare systems, employees and shareholders.
